108 related articles for article (PubMed ID: 11102619)
1. DNA-ploidy as an independent prognostic factor in patients with serous ovarian carcinoma.
But I; Gorisek B
Int J Gynaecol Obstet; 2000 Dec; 71(3):259-62. PubMed ID: 11102619
[No Abstract] [Full Text] [Related]
2. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
Curling M; Stenning S; Hudson CN; Watson JV
J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy as a prognostic factor in patients with ovarian carcinoma.
Pietrzak K; Olszewski W
Pol J Pathol; 1998; 49(3):141-4. PubMed ID: 9810171
[TBL] [Abstract][Full Text] [Related]
4. [Heterogeneity of epithelial ovarian carcinomas and their clinical significance].
Noske A
Praxis (Bern 1994); 2014 Jan; 103(3):155-9. PubMed ID: 24468455
[TBL] [Abstract][Full Text] [Related]
5. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
Tropé CG; Abeler V; Baekelandt M; Kaern J
Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
[TBL] [Abstract][Full Text] [Related]
8. Cellular DNA content and survival in advanced ovarian carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary.
Bakshi N; Rajwanshi A; Patel F; Ganguly NK
Anal Quant Cytol Histol; 1998 Jun; 20(3):215-20. PubMed ID: 9642449
[TBL] [Abstract][Full Text] [Related]
10. Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy.
Zangwill BC; Balsara G; Dunton C; Varello M; Rebane BA; Hernandez E; Atkinson BF
Cancer; 1993 Apr; 71(7):2261-7. PubMed ID: 8453547
[TBL] [Abstract][Full Text] [Related]
11. High levels of genomic aberrations in serous ovarian cancers are associated with better survival.
Baumbusch LO; Helland Å; Wang Y; Liestøl K; Schaner ME; Holm R; Etemadmoghadam D; Alsop K; Brown P; ; Mitchell G; Fereday S; DeFazio A; Bowtell DD; Kristensen GB; Lingjærde OC; Børresen-Dale AL
PLoS One; 2013; 8(1):e54356. PubMed ID: 23372714
[TBL] [Abstract][Full Text] [Related]
12. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
[TBL] [Abstract][Full Text] [Related]
13. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
Lassus H; Staff S; Leminen A; Isola J; Butzow R
Gynecol Oncol; 2011 Jan; 120(1):11-7. PubMed ID: 20937525
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
Novik VI; Gevorkian VA; Maksimov SIa
Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
[TBL] [Abstract][Full Text] [Related]
15. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry as a new prognostic factor in ovarian malignancies. A review.
Tropé C; Makar A; Kaern J
Acta Obstet Gynecol Scand Suppl; 1992; 155():95-7. PubMed ID: 1502897
[No Abstract] [Full Text] [Related]
17. DNA ploidy in epithelial ovarian cancer: a new independent prognostic factor?
Tropé C; Kaern J
Gynecol Oncol; 1994 Apr; 53(1):1-4. PubMed ID: 8175006
[No Abstract] [Full Text] [Related]
18. DNA ploidy analysis of borderline epithelial ovarian tumours.
Lodhi S; Najam S; Pervez S
J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
